KANK2 and Sepsis: In conclusion, we have demonstrated that HSP70 interacted with KANK2 to reduce apoptotic cell and that application of exogenous HSP70 is a novel potential therapeutic approach for lung injury secondary to sepsis by impairment of apoptotic cellular pathway and amelioration of pulmonary dysfunction secondary to CLP in mice.